Verastem Oncology (VSTM) Misses Q3 EPS by 54c

Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.54). Revenue for the quarter came in at $11.24 million.

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Meta pauses an AI training program that tracks employees' keystrokes after a companywide leak - Insider